Developer docs
API playgroundTry for free, no card

Search company profiles

RSIP Vision

Full company profile

uuid00077n8

Namestring
RSIP Vision
Legal namestring
RSIP Vision
Websiteurl
rsipvision.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

RSIP Vision is a privately held Israeli software company specializing in custom AI, deep learning, and computer vision solutions for medical image analysis. Founded in 1987 (with a 2000 incorporation date also cited in sources) and headquartered in Jerusalem, the company serves medical device manufacturers as its primary customer segment, embedding AI capabilities into OEM products across clinical specialties including orthopedics, cardiology, gastroenterology, urology, surgery, ENT, pulmonology, and ophthalmology. Its technology spans image segmentation, registration, tracking, 3D reconstruction, and real-time surgical navigation across CT, MRI, X-ray, ultrasound, endoscopy, and microscopy modalities, with disclosed benchmarks including sub-millimeter 2D-to-3D reconstruction accuracy validated in a peer-reviewed clinical study and 25-30 fps navigation update rates.

The company operates a platform-plus-modules architecture built around an RSIP Vision Core Platform and a portfolio of specialized modules (Bone Segmentation, Cartilage Assessment, Intraoperative Registration, Navigation Systems, IBD Scoring, Prostate Guidance, etc.), supplemented by two wholly-owned subsidiaries: XPlan.ai (2D-to-3D bone reconstruction from X-rays, with FDA clearance in pursuit) and RSIP Neph (AI-based intraoperative visual intelligence for urological procedures such as partial nephrectomy). The portfolio is supported by an in-house MLOps framework built on ClearML that handles versioning, experiment tracking, and model lineage for FDA-grade regulatory submissions. Named enterprise customers include Hologic, Activ Surgical, LinkBio, Biosense Webster (Johnson & Johnson), Clario, and GI Reviewers, with clinical research collaboration via Assuta Medical Center.

RSIP Vision generates revenue through project-based custom R&D development fees combined with OEM/embedded technology licensing arrangements, with pricing negotiated on a per-project basis and not publicly disclosed. Go-to-market is enterprise field sales led by CEO Ron Soferman and VP of Business Development Shmulik Shpiro, supported by presence at major medical conferences (AAOS, SAGES, AUA, NASS, DeviceTalks), a Computer Vision News magazine reaching 8,000+ professionals, and a technical blog. The firm has 51-100 employees, offices in Jerusalem, Tel Aviv, and San Jose, no disclosed external funding or valuation, and appears to be founder/management-owned.

Short descriptiontext

RSIP Vision is a privately held Israel-based software company that develops custom AI, deep learning, and computer vision algorithms for medical image analysis, embedding its technology as OEM components in medical devices across orthopedics, cardiology, gastroenterology, urology, and surgical specialties.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersJerusalem, Israel
HQ citystring
Jerusalem
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical image analysis, computer vision software, AI medical imaging, deep learning healthcare, surgical navigation systems
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Image Analysis Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Custom Software Development & Licensing
TypeLicensing Royalties
Description

RSIP Vision develops custom computer vision and AI solutions for medical device companies, likely through project-based development fees and/or licensing arrangements. The company works through a transparent process from concept development through prototype, implementation, and productization, suggesting a combination of R&D services and embedded technology licensing.

rsipvision.com
2XPlan.ai Technology Licensing
TypeOne Time License
Description

The company's spinoff XPlan.ai provides AI-based 3D bone reconstructions from standard 2D X-rays for orthopedic applications. This technology is being developed for FDA clearance and represents a potential product licensing opportunity.

rsipvision.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1XPlan.ai
Description

AI-based solution that provides 3D bone reconstructions from standard 2D X-rays for orthopedic surgery planning, including knee replacement procedures. Spinoff company of RSIP Vision.

rsipvision.com
+1 more record
Core offering1 text field

RSIP Vision develops custom computer vision and deep learning software for medical image analysis, providing algorithms and OEM-embedded AI capabilities to medical device manufacturers. The company delivers solutions across imaging modalities (CT, MRI, X-ray, ultrasound, endoscopy, microscopy) for segmentation, registration, tracking, 3D reconstruction, and intraoperative guidance, with end-to-end support from concept development through FDA regulatory productization.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Sub-millimeter accuracy achieved in peer-reviewed clinical study for 2D-to-3D knee reconstruction using XPlan.ai technology
+3 more records
Product overview1 text field

RSIP Vision is a world-class pioneer in medical image analysis and AI, offering field-tested software solutions and custom R&D prowess to power medical devices. The company operates a platform-plus-modules architecture with its core RSIP Vision platform providing AI capabilities across multiple medical specialties (cardiology, orthopedics, gastro, pulmonology, surgical, ENT, urology, ophthalmology). The portfolio includes specialized sub-brands XPlan.ai (2D-to-3D bone reconstruction from X-rays) and RSIP Neph (urology/partial nephrectomy solutions), plus various add-on modules for segmentation, registration, navigation, and procedure-specific guidance. The company focuses on custom R&D services, clinical validation, and FDA regulatory support rather than off-the-shelf products.

Product and service1 record
1RSIP Vision Custom AI/Computer Vision Development for Medical Devices
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-06
Description

Strategic partnership for developing AI-based scoring system for Inflammatory Bowel Disease (IBD) clinical trials. Clario provides scientific leadership and clinical trials infrastructure; RSIP Vision provides AI technology. The solution automatically computes Mayo Endoscopic Score from colonoscopy videos, improving reproducibility and efficiency of clinical trial assessments.

2GI Reviewers
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-06
Description

Partnership providing clinical guidance and central reading expertise for IBD scoring AI development. GI Reviewers, led by Dr. Daniel Mishkin, contributes gastroenterology domain expertise and supervision for AI algorithm training using expert-scored colonoscopy videos.

rsipvision.com
3Assuta Medical Center
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical research partnership for evaluating XPlan.ai technology. The study was conducted using imaging from total knee replacement patients at Assuta Medical Center in Tel-Aviv, a leading medical center in Israel. Dr. Shai Factor and Dr. Vadim Benkovich from Assuta participated in the peer-reviewed clinical study.

rsipvision.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major medical imaging OEM (CT, MRI, ultrasound, X-ray) integrating AI capabilities into devices. Comparable as a large incumbent with embedded imaging AI that competes for the same OEM and hospital relationships.

TypeDirect peer
Description

AI software for medical imaging, most notably for stroke detection and workflow coordination. Comparable as a clinical imaging AI company whose algorithms integrate into hospital and OEM imaging workflows.

TypeDirect peer
Description

AI-driven cardiovascular imaging analysis using CT scans to assess coronary artery disease. Comparable as a medical imaging AI company focused on a specific clinical specialty (cardiology) with regulatory-cleared product.

TypeDirect peer
Description

AI-powered medical imaging biomarker analysis for radiology and oncology. Comparable as a medical imaging AI software provider with multi-modality and multi-specialty coverage.

TypeDirect peer
Description

AI for medical imaging enhancement (faster MRI, lower-dose PET). Comparable as an AI medical imaging software company focused on image acquisition and analysis quality.

TypeDirect peer
Description

Cloud-native AI medical imaging platform with FDA-cleared products across multiple imaging modalities. Comparable as a medical imaging AI software company with regulatory-cleared offerings.

TypeBroad incumbent
Description

Global medical imaging and diagnostics equipment OEM with embedded AI capabilities across CT, MRI, ultrasound. Comparable as a large incumbent offering AI-augmented imaging software as part of a broader medical device portfolio.

TypeDirect peer
Description

AI-based medical imaging analysis focused on brain MRI/CT. Comparable as a specialty-focused medical imaging AI software company with FDA-cleared products serving clinical workflows.

TypeDirect peer
Description

AI-powered medical imaging platform providing clinical decision support across CT and other modalities. Directly comparable as a medical imaging AI software provider serving hospitals and integrated with imaging workflows.

TypeDirect peer
Description

AI for digital pathology and cancer detection in medical imaging. Comparable as an AI medical imaging company developing FDA-cleared diagnostic software for clinical use.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability18 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RSIP Vision

Medical Image Analysis Softwarersipvision.com

RSIP Vision is a privately held Israel-based software company that develops custom AI, deep learning, and computer vision algorithms for medical image analysis, embedding its technology as OEM components in medical devices across orthopedics, cardiology, gastroenterology, urology, and surgical specialties.

What RSIP Vision does

RSIP Vision is a privately held Israeli software company specializing in custom AI, deep learning, and computer vision solutions for medical image analysis. Founded in 1987 (with a 2000 incorporation date also cited in sources) and headquartered in Jerusalem, the company serves medical device manufacturers as its primary customer segment, embedding AI capabilities into OEM products across clinical specialties including orthopedics, cardiology, gastroenterology, urology, surgery, ENT, pulmonology, and ophthalmology. Its technology spans image segmentation, registration, tracking, 3D reconstruction, and real-time surgical navigation across CT, MRI, X-ray, ultrasound, endoscopy, and microscopy modalities, with disclosed benchmarks including sub-millimeter 2D-to-3D reconstruction accuracy validated in a peer-reviewed clinical study and 25-30 fps navigation update rates.

The company operates a platform-plus-modules architecture built around an RSIP Vision Core Platform and a portfolio of specialized modules (Bone Segmentation, Cartilage Assessment, Intraoperative Registration, Navigation Systems, IBD Scoring, Prostate Guidance, etc.), supplemented by two wholly-owned subsidiaries: XPlan.ai (2D-to-3D bone reconstruction from X-rays, with FDA clearance in pursuit) and RSIP Neph (AI-based intraoperative visual intelligence for urological procedures such as partial nephrectomy). The portfolio is supported by an in-house MLOps framework built on ClearML that handles versioning, experiment tracking, and model lineage for FDA-grade regulatory submissions. Named enterprise customers include Hologic, Activ Surgical, LinkBio, Biosense Webster (Johnson & Johnson), Clario, and GI Reviewers, with clinical research collaboration via Assuta Medical Center.

RSIP Vision generates revenue through project-based custom R&D development fees combined with OEM/embedded technology licensing arrangements, with pricing negotiated on a per-project basis and not publicly disclosed. Go-to-market is enterprise field sales led by CEO Ron Soferman and VP of Business Development Shmulik Shpiro, supported by presence at major medical conferences (AAOS, SAGES, AUA, NASS, DeviceTalks), a Computer Vision News magazine reaching 8,000+ professionals, and a technical blog. The firm has 51-100 employees, offices in Jerusalem, Tel Aviv, and San Jose, no disclosed external funding or valuation, and appears to be founder/management-owned.

RSIP Vision firmographics

Firmographics
Name
RSIP Vision
Legal name
RSIP Vision
Website
https://rsipvision.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
11–50 employees
Short description
RSIP Vision is a privately held Israel-based software company that develops custom AI, deep learning, and computer vision algorithms for medical image analysis, embedding its technology as OEM components in medical devices across orthopedics, cardiology, gastroenterology, urology, and surgical specialties.
Ownership category
akta.pro rank

RSIP Vision industry classification

Industry
Product category
Medical Image Analysis Software
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAHADAD
Surgical Visualization & OR Video Integration (4K/3D, Recording, Routing)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

Keywords

  • Medical image analysis
  • Computer vision software
  • AI medical imaging
  • Deep learning healthcare
  • Surgical navigation systems

Where RSIP Vision is headquartered

Location

Headquarters

HQ city
Jerusalem
HQ country
Israel
HQ region
Middle East

Offices3 records

Markets served

RSIP Vision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Custom Software Development & Licensing: RSIP Vision develops custom computer vision and AI solutions for medical device companies, likely through project-based development fees and/or licensing arrangements. The company works through a transparent process from concept development through prototype, implementation, and productization, suggesting a combination of R&D services and embedded technology licensing.
  2. XPlan.ai Technology Licensing: The company's spinoff XPlan.ai provides AI-based 3D bone reconstructions from standard 2D X-rays for orthopedic applications. This technology is being developed for FDA clearance and represents a potential product licensing opportunity.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels7 records

RSIP Vision product offering

Product offering

Core offering

RSIP Vision develops custom computer vision and deep learning software for medical image analysis, providing algorithms and OEM-embedded AI capabilities to medical device manufacturers. The company delivers solutions across imaging modalities (CT, MRI, X-ray, ultrasound, endoscopy, microscopy) for segmentation, registration, tracking, 3D reconstruction, and intraoperative guidance, with end-to-end support from concept development through FDA regulatory productization.

Product overview

RSIP Vision is a world-class pioneer in medical image analysis and AI, offering field-tested software solutions and custom R&D prowess to power medical devices. The company operates a platform-plus-modules architecture with its core RSIP Vision platform providing AI capabilities across multiple medical specialties (cardiology, orthopedics, gastro, pulmonology, surgical, ENT, urology, ophthalmology). The portfolio includes specialized sub-brands XPlan.ai (2D-to-3D bone reconstruction from X-rays) and RSIP Neph (urology/partial nephrectomy solutions), plus various add-on modules for segmentation, registration, navigation, and procedure-specific guidance. The company focuses on custom R&D services, clinical validation, and FDA regulatory support rather than off-the-shelf products.

Differentiator

Problem solved

Functional benefit

Brands

  • XPlan.ai: AI-based solution that provides 3D bone reconstructions from standard 2D X-rays for orthopedic surgery planning, including knee replacement procedures. Spinoff company of RSIP Vision.
  • RSIP Neph

Products and services

  • RSIP Vision Custom AI/Computer Vision Development for Medical Devices

Quantifiable outcome

  • Sub-millimeter accuracy achieved in peer-reviewed clinical study for 2D-to-3D knee reconstruction using XPlan.ai technology
  • +3 more outcomes

Companies that use RSIP Vision

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles2 records

RSIP Vision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability18 records

Feature8 records

RSIP Vision partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • ClariocoreStrategic or Co-development Partner · 6 March 2023Strategic partnership for developing AI-based scoring system for Inflammatory Bowel Disease (IBD) clinical trials. Clario provides scientific leadership and clinical trials infrastructure; RSIP Vision provides AI technology. The solution automatically computes Mayo Endoscopic Score from colonoscopy videos, improving reproducibility and efficiency of clinical trial assessments.
  • GI ReviewerscoreStrategic or Co-development Partner · 6 March 2023Partnership providing clinical guidance and central reading expertise for IBD scoring AI development. GI Reviewers, led by Dr. Daniel Mishkin, contributes gastroenterology domain expertise and supervision for AI algorithm training using expert-scored colonoscopy videos.
  • Assuta Medical CentercoreStrategic or Co-development PartnerClinical research partnership for evaluating XPlan.ai technology. The study was conducted using imaging from total knee replacement patients at Assuta Medical Center in Tel-Aviv, a leading medical center in Israel. Dr. Shai Factor and Dr. Vadim Benkovich from Assuta participated in the peer-reviewed clinical study.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

RSIP Vision competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: Major medical imaging OEM (CT, MRI, ultrasound, X-ray) integrating AI capabilities into devices. Comparable as a large incumbent with embedded imaging AI that competes for the same OEM and hospital relationships.
  • Siemens Healthineers: Global medical imaging and diagnostics equipment OEM with embedded AI capabilities across CT, MRI, ultrasound. Comparable as a large incumbent offering AI-augmented imaging software as part of a broader medical device portfolio.

Direct peers

  • Viz.ai: AI software for medical imaging, most notably for stroke detection and workflow coordination. Comparable as a clinical imaging AI company whose algorithms integrate into hospital and OEM imaging workflows.
  • HeartFlow: AI-driven cardiovascular imaging analysis using CT scans to assess coronary artery disease. Comparable as a medical imaging AI company focused on a specific clinical specialty (cardiology) with regulatory-cleared product.
  • Quibim: AI-powered medical imaging biomarker analysis for radiology and oncology. Comparable as a medical imaging AI software provider with multi-modality and multi-specialty coverage.
  • Subtle Medical: AI for medical imaging enhancement (faster MRI, lower-dose PET). Comparable as an AI medical imaging software company focused on image acquisition and analysis quality.
  • Arterys (Tempus): Cloud-native AI medical imaging platform with FDA-cleared products across multiple imaging modalities. Comparable as a medical imaging AI software company with regulatory-cleared offerings.
  • icometrix: AI-based medical imaging analysis focused on brain MRI/CT. Comparable as a specialty-focused medical imaging AI software company with FDA-cleared products serving clinical workflows.
  • Aidoc: AI-powered medical imaging platform providing clinical decision support across CT and other modalities. Directly comparable as a medical imaging AI software provider serving hospitals and integrated with imaging workflows.
  • Paige.AI: AI for digital pathology and cancer detection in medical imaging. Comparable as an AI medical imaging company developing FDA-cleared diagnostic software for clinical use.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

RSIP Vision social profiles

Digital presence

RSIP Vision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RSIP Vision leadership team

Management profile

Number of profiles

Profiles8 records

RSIP Vision subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

RSIP Vision funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RSIP Vision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RSIP Vision

What does RSIP Vision do?

RSIP Vision develops custom computer vision and deep learning software for medical image analysis, providing algorithms and OEM-embedded AI capabilities to medical device manufacturers. The company delivers solutions across imaging modalities (CT, MRI, X-ray, ultrasound, endoscopy, microscopy) for segmentation, registration, tracking, 3D reconstruction, and intraoperative guidance, with end-to-end support from concept development through FDA regulatory productization.

Is RSIP Vision a public or private company?

RSIP Vision is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RSIP Vision founded?

RSIP Vision was founded in 2000. It employs 11 to 50 people.

Where is RSIP Vision based?

RSIP Vision is headquartered in Jerusalem, Israel, in the Middle East region.

How does RSIP Vision make money?

Two revenue lines are on record. Custom Software Development & Licensing is the primary driver. The others are XPlan.ai Technology Licensing.

Who are RSIP Vision's main competitors?

Broad incumbents on record are GE HealthCare and Siemens Healthineers. Direct peers are Viz.ai, HeartFlow, Quibim, Subtle Medical, Arterys (Tempus), icometrix, Aidoc and Paige.AI.

Does RSIP Vision have an API?

No public API is recorded for RSIP Vision.

What industry is RSIP Vision in?

RSIP Vision's product category is Medical Image Analysis Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireXPlan.ai Confirms Premier Precision in Peer-Reviewed Clinical Study of its 2D-to-3D Knee Reconstruction SolutionXPlan.ai, an AI spinoff of RSIP Vision, announced that its X-ray based 3D knee reconstruction solution achieved sub-millimeter accuracy in a peer-reviewed clinical study published in the Journal of Clinical Medicine. The study, led by a consortium of orthopedic surgeons, confirmed the technology as a viable alternative to conventional CT scans for image-based computer-assisted surgery. The solution offers benefits including cost savings, increased efficiency, and reduced radiation exposure for patients.PR NewswireRising Healthcare Expenditures Propel Ulcerative Colitis Market - Expected to Surpass $8.86 Billion by 2027ResearchAndMarkets.com announced the addition of the "Ulcerative Colitis Global Market Report 2023" to its offerings, projecting the global market to grow from $6.35 billion in 2022 to $8.86 billion by 2027 at a CAGR of 6.7%, driven by rising healthcare expenditures and technological advancements. The report highlights Pfizer's $6.7 billion acquisition of Arena Pharmaceuticals in March 2022 and an AI-based rating system launched by Clario ERT Inc., GI Reviewers LLC, and RSIP Vision in March 2023 as key industry developments. North America dominated the market in 2022, with the report covering global regions including the USA, China, Germany, Japan, India, and the UK.PR NewswireClario, GI Reviewers and RSIP Vision Team Up to Present a New AI Solution to Advance Clinical Trials for Inflammatory Bowel DiseasesClario, GI Reviewers, and RSIP Vision announced an AI-based system to score inflammatory bowel disease colonoscopy videos, trained on over 100,000 images. The system achieves human-level performance and is being extended to Crohn's disease scoring. Upcoming plans include AI-enabled enrollment automation and deeper analytics.PR NewswireRSIP Neph Announces a Revolutionary Intra-op Solution for Partial Nephrectomy SurgeriesRSIP Neph, part of the RSIP Vision group, announced a new intra-operative solution for partial nephrectomy surgeries that uses AI-based visual intelligence to overlay vital information on real-time video feeds. Developed in collaboration with Israel's largest urology department, the technology aims to improve surgical precision by revealing hidden lesions and body structures to surgeons during robotic procedures.PR NewswireRSIP Vision Presents Successful Preliminary Results from Clinical Study of 2D-to-3D Knee Bones ReconstructionRSIP Vision announced preliminary results from an ongoing clinical study evaluating its AI-based 2D-to-3D knee reconstruction tool at Assuta Medical Center in Tel Aviv, demonstrating high accuracy in producing 3D knee models from standard X-ray images. The technology aims to enable surgical planning for knee replacements without requiring CT scans, offering clinical benefits including lower radiation exposure and operational advantages such as better accessibility and lower cost. The company plans to expand the clinical study to a U.S. medical center and pursue FDA clearance, while also extending the solution to hip and shoulder joints.PR NewswireRSIP Vision Presents New Urological AI Tool for 3D Reconstruction of the Ureter Improving Urological ProceduresRSIP Vision announced a new AI-powered tool that reconstructs accurate 3D models of the ureter from 2D fluoroscopic images for use in urological procedures. The technology uses deep-learning algorithms to transform at least two fluoroscopic images from different angles into a CT-grade 3D model, enabling physicians to use it for diagnosis, procedural planning, and real-time navigation during procedures like ureteroplasty, stent placement, and stone retrieval. The vendor-neutral tool will be made available to third-party medical device manufacturers using C-arm imaging systems.BioWorldRsip Vision presents intra-op virtual measurements for laparoscopic and robot-assisted surgeriesRsip Vision Ltd. released a new technology for intraoperative video analysis that provides real-time, accurate anatomical measurements in surgical videos. The offering supports clinical use cases such as bariatric surgery and small bowel resection.BioWorldRsip Vision releases joint segmentation tool for revision arthroplasty and other orthopedic proceduresRsip Vision, an Israel and U.S.-based company, unveiled an AI-based joint segmentation tool for planning revision arthroplasty and other orthopedic procedures. The noninvasive software module segments hips, knees, shoulders, and spines from CT scans, aiding quick and accurate planning for patients with pre-existing metal implants.Tech Company NewsRSIP Vision Drives Technological Innovation In The Medical Imaging Space Through Advanced AI And Computer Vision SoftwareRSIP Vision, a company with over 25 years in medical imaging AI, developed modules for coronary artery 3D modeling and cardiac ultrasound analysis. The company plans to expand into orthopedics, endoscopy, urology, and echocardiology, and continues to work with medical advisers to bridge technology and device needs.